Aquestive Therapeutics, Inc. AQST Common stock, shares authorized (in shares)
Common stock, shares authorized (in shares) at other companies
Other financials
Where this comes from
Reported directly by Aquestive Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.
The official record: Aquestive Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aquestive Therapeutics, Inc.'s common stock, shares authorized (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aquestive Therapeutics, Inc.'s common stock, shares authorized (in shares)?
- Aquestive Therapeutics, Inc. (AQST) reported common stock, shares authorized (in shares) of $250M in Q1 2026.
- How has Aquestive Therapeutics, Inc.'s common stock, shares authorized (in shares) changed year-over-year?
- Aquestive Therapeutics, Inc.'s common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $250M to $250M.
- What is the long-term trend for Aquestive Therapeutics, Inc.'s common stock, shares authorized (in shares)?
- Over 5 years (2020 to 2025), Aquestive Therapeutics, Inc.'s common stock, shares authorized (in shares) has grown at a 0.0% compound annual growth rate (CAGR), from $250M to $250M.